Megan Melody, Clinical Director of Cellular Therapy at Tampa General Hospital, shared on LinkedIn:
“Excited to announce the publication of our review, ‘Sequencing CD19-targeted therapies in patients with relapsed refractory large B-cell lymphoma,’ in Blood Reviews.
A huge effort from a wonderful group of coauthors!”
Title: Sequencing CD19-targeted therapies in patients with relapsed/refractory large B-cell lymphoma: A narrative review
Authors: Paolo F. Caimi, Romano Danesi, Gloria Iacoboni, Manali Kamdar, Megan Melody, Mehdi Hamadani.
Read the Full Article.
